Safe and informed prescribing of psychotropic medication during the COVID-19 pandemic.
Br J Psychiatry
; 217(3): 471-474, 2020 09.
Article
in English
| MEDLINE | ID: covidwho-154518
ABSTRACT
Treatment with psychotropic medication may sometimes be jeopardised because of the COVID-19 pandemic. One underlying reason is the lack of COVID-19-specific psychopharmacology guidelines. Here, we discuss five considerations arising from our clinical experience and pharmacological background knowledge to enable safe and well-informed psychopharmacotherapy during the COVID-19 pandemic.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Anxiety
/
Pneumonia, Viral
/
Psychotherapy
/
Psychotropic Drugs
/
Practice Patterns, Physicians'
/
Coronavirus Infections
/
Pandemics
/
Mental Disorders
Type of study:
Observational study
/
Prognostic study
/
Qualitative research
Limits:
Humans
Country/Region as subject:
Europa
Language:
English
Journal:
Br J Psychiatry
Year:
2020
Document Type:
Article
Affiliation country:
Bjp.2020.92
Similar
MEDLINE
...
LILACS
LIS